In this essay, we offer the opinion that engineered nanomaterials are, by definition, materials that can interact with biological systems at the nanoscale, and that this very fact underlies both the promise and the peril of this multifaceted class of materials. Furthermore, nanomaterials are cloaked in host-derived proteins, lipids, or other biomolecules as they enter into a living organism and this so-called bio-corona may impact on subsequent interactions with biological structures. We will explore some examples of nanoscale effects of engineered nanomaterials, and discuss how such interactions may underpin toxicity, and, conversely, how nanoscale interactions may be harnessed for clinical applications, including the use of nanoparticles as drugs per se.
CITATION STYLE
Gallud, A., & Fadeel, B. (2015, June 1). Keeping it small: Towards a molecular definition of nanotoxicology. European Journal of Nanomedicine. Walter de Gruyter GmbH. https://doi.org/10.1515/ejnm-2015-0020
Mendeley helps you to discover research relevant for your work.